Qun K. Fang
Sunovion
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Qun K. Fang.
Tetrahedron-asymmetry | 2000
Qun K. Fang; Zhengxu Han; Paul Grover; Donald W. Kessler; Chris H. Senanayake; Stephen A. Wald
Abstract A stereospecific method for the synthesis of enantiopure α-aminoketone from its corresponding α-hydroxy-ketone via the triflate intermediate is discussed. This strategy provides a rapid and efficient route for the preparation of either enantiomer of bupropion and its biologically active hydroxylated metabolite.
Tetrahedron-asymmetry | 1999
Qun K. Fang; Chris H. Senanayake; Zhengxu Han; Cynthia Morency; Paul Grover; Robert E Malone; Hal Bulter; Stephen A. Wald; T. Stanley Cameron
Abstract Racemic sibutramine was resolved with dibenzoyl- d -tartaric acid, and the absolute stereochemistry of sibutramine was determined by single crystal X-ray crystallography of its dibenzoyl d -tartrate. The major active metabolite (desmethylsibutramine) was obtained by demethylation of sibutramine with DEAD. Enantiomeric purity of sibutramine was determined by HPLC on an Ultron ES-OVM column.
Tetrahedron Letters | 1998
Qun K. Fang; Chris H. Senanayake; H. Scott Wilkinson; Stephen A. Wald; Hui Li
Abstract An efficient and practical method for the synthesis of racemic and optically active (96% ee) fexofenadine is described. The key racemic or optically active lactol intermediate 2 is prepared from readily available tolyl derivative 3 .
Tetrahedron-asymmetry | 2002
Zhengxu Han; Dhileepkumar Krishnamurthy; Derek Pflum; Qun K. Fang; Hal T. Butler; T. Stanley Cameron; Stephen A. Wald; Chris H. Senanayake
A practical synthesis of enantiomerically pure (R)-desmethylsibutramine [(R)-DMS] and (S)-desmethylsibutramine [(S)-DMS] is outlined along with an improved synthesis of racemic desmethylsibutramine. This route was used for kilo-scale production of enantiomerically pure (R)- and (S)-DMS. Racemic desmethylsibutramine was resolved with either (R)- or (S)-mandelic acid, and the absolute stereochemistry of DMS was determined by single X-ray crystallography of its mandelate salt.
Tetrahedron-asymmetry | 2000
Yaping Hong; Roger P. Bakale; Qun K. Fang; Tingjian Xiang; Zhengxu Han; Fran X. McConville; Chris H. Senanayake; Stephen A. Wald
Abstract Two synthetic methods have been established for the preparation of enantiomerically pure desmethylzopiclone, a metabolite of zopiclone. In Method A, (S)-desmethylzopiclone was prepared by demethylation of (S)-zopiclone with 1-chloroethyl chloroformate in high yield. Enantiomerically pure zopiclone (>99% ee) was obtained through a highly efficient resolution process in >36% overall yield. In Method B, racemic desmethylzopiclone was resolved with l -N-benzyloxycarbonyl phenylalanine ( l -ZPA) followed by recrystallization in good yield. The absolute stereochemistry of the (+)-enantiomer was first determined to be the (S)-configuration by X-ray crystallography.
Organic Process Research & Development | 1998
Robert Hett; Qun K. Fang; Yun Gao; and Stephen A. Wald; Chris H. Senanayake
Archive | 2003
Thomas P. Jerussi; Qun K. Fang
Archive | 2001
Thomas P. Jerussi; Chrisantha H. Senanayake; Qun K. Fang
Archive | 2002
Chris H. Senanayake; Thomas P. Jerussi; Mark G. Currie; Qun K. Fang; Bob Hsu
Archive | 2001
Thomas P. Jerussi; Chrisantha H. Senanayake; Qun K. Fang